美因基因(06667.HK)中期經調整淨利3300萬元 同比下降24.2%
美因基因(06667.HK)公吿,截至2022年6月30日止6個月,收入人民幣9760萬元,同比增加為0.8%。公司的經調整淨利潤為人民幣3300萬元,同比下降24.2%。於同期,公司的經調整淨利潤率自44.9%下降至33.8%,主要是由於公司加大市場推廣力度,增加營銷人員儲備導致人員成本增加。同時,隨着研發進度推進,部分項目進入到臨牀實驗階段,樣本量增加,各種試劑、測序等費用增加。母公司普通權益持有人應占每股盈利人民幣0.09元。
據悉,消費級基因檢測服務同比收入下降,主要由於新型冠狀病毒相關檢測服務所得收入大幅減少,乃由於政府要求降低新型冠狀病毒診斷檢測的價格所致。癌症篩查服務的收入呈現穩定且一貫的增長趨勢,乃由於優化產品及服務組合(經優化的產品及服務組合專注於該等平均單價及毛利率相對較高的檢測服務)及公司有效控制成本的能力所促使。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.